Finance

Lists
CYYNF:OTCMKTS
Cynata Therapeutics Ltd
0,0086 $
0,00%
(0,00) 1D
4 օգս, 09:54:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CYYNF...
Mkt. cap
2,95 մլն
Avg. vol.
112,00
Volume
0,00
52-wk high
0,22 $
52-wk low
0,00 $
Shares outstanding
243,45 մլն
No. of employees
0
Mkt. cap
2,95 մլն
Avg. vol.
112,00
Volume
0,00
52-wk high
0,22 $
52-wk low
0,00 $
Shares outstanding
243,45 մլն
No. of employees
0
News stories
From web sources and news partners
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
Sector-
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
855,81 հզր
855,81 հզր
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2,69 մլն
2,69 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,69 մլն
1,69 մլն
-763,69 հզր
-763,69 հզր
Operating expense
2,22 մլն
2,22 մլն
2,55 մլն
2,55 մլն
Total operating expenses
2,22 մլն
2,22 մլն
2,55 մլն
2,55 մլն
Operating income
-1,36 մլն
-1,36 մլն
-2,55 մլն
-2,55 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-1,33 մլն
-1,33 մլն
-3,21 մլն
-3,21 մլն
EBT excluding unusual items
-1,33 մլն
-1,33 մլն
-2,54 մլն
-2,54 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425,31 հզր
425,31 հզր
528,16 հզր
528,16 հզր
Net income
-1,33 մլն
-1,33 մլն
-3,21 մլն
-3,21 մլն
Net profit margin
-155,55%
-155,55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
30,33 հզր
30,33 հզր
9,42 հզր
9,42 հզր
Interest expense
-
-
-
-
Net interest expenses
30,33 հզր
30,33 հզր
9,42 հզր
9,42 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,30 մլն
-1,30 մլն
-2,48 մլն
-2,48 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps